Skip to Content
Merck
CN
All Photos(1)

Documents

Safety Information

BP729

Estradiol hemihydrate

British Pharmacopoeia (BP) Assay Standard

Synonym(s):

β-Estradiol hemihydrate, 1,3,5-Estratriene-3,17β-diol, 3,17β-Dihydroxy-1,3,5(10)-estratriene

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C18H24O2 · 0.5H2O
CAS Number:
35380-71-3
Molecular Weight:
281.39
Beilstein:
1914275
EC Number:
200-023-8
MDL number:
MFCD23102821
UNSPSC Code:
41116107
NACRES:
NA.24

grade

pharmaceutical primary standard

API family

estradiol

form

powder

shelf life

limited shelf life, expiry date on the label

manufacturer/tradename

BP

application(s)

pharmaceutical
pharmaceutical small molecule

format

neat

storage temp.

2-8°C

SMILES string

O.C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O.C[C@]56CC[C@H]7[C@@H](CCc8cc(O)ccc78)[C@@H]5CC[C@@H]6O

InChI

1S/2C18H24O2.H2O/c2*1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20;/h2*3,5,10,14-17,19-20H,2,4,6-9H2,1H3;1H2/t2*14-,15-,16+,17+,18+;/m11./s1

InChI key

ZVVGLAMWAQMPDR-WVEWYJOQSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Estradiol hemihydrate BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:
  • Estradiol and Norethisterone Tablets
  • Estradiol and Norethisterone Acetate Tablets
  • Estradiol Tablets
  • Estradiol Vaginal Tablets
  • Estradiol Transdermal Patches

    • Packaging

    Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

    Other Notes

    Sales restrictions may apply.

    related product

    Product No.
    Description
    Pricing

    1250008

    Estradiol, United States Pharmacopeia (USP) Reference Standard

    Y0000314

    Estradiol for peak identification, European Pharmacopoeia (EP) Reference Standard

    E1620000

    Estradiol hemihydrate, European Pharmacopoeia (EP) Reference Standard

    E1600000

    Estradiol benzoate, European Pharmacopoeia (EP) Reference Standard

    Y0000046

    Estradiol valerate, European Pharmacopoeia (EP) Reference Standard

    Y0000852

    Estradiol benzoate for system suitability, European Pharmacopoeia (EP) Reference Standard

    1252003

    Estradiol cypionate, United States Pharmacopeia (USP) Reference Standard

    1251000

    Estradiol benzoate, United States Pharmacopeia (USP) Reference Standard

    1254009

    Estradiol valerate, United States Pharmacopeia (USP) Reference Standard

    1250041

    Estradiol Related Compound C, United States Pharmacopeia (USP) Reference Standard

    1250020

    Estradiol Related Compound B, United States Pharmacopeia (USP) Reference Standard

    1252193

    Estradiol cypionate System Suitability Mixture, United States Pharmacopeia (USP) Reference Standard

    Y0001823

    Estradiol valerate for system suitability, European Pharmacopoeia (EP) Reference Standard

    BP396

    Estradiol benzoate, British Pharmacopoeia (BP) Reference Standard

    1254031

    Estradiol Valerate Identification Mixture, United States Pharmacopeia (USP) Reference Standard

    PHR2228

    Estradiol 3-Methyl Ether, Pharmaceutical Secondary Standard; Certified Reference Material

    PHR2227

    Estradiol Impurity L, Pharmaceutical Secondary Standard; Certified Reference Material

    PHR2839

    Estradiol Cypionate, certified reference material, pharmaceutical secondary standard

    PHR2857

    Estradiol Valerate, certified reference material, pharmaceutical secondary standard

    PHR2858

    Estradiol Benzoate, certified reference material, pharmaceutical secondary standard

    PHR2859

    Estradiol Related Compound C, pharmaceutical secondary standard, certified reference material

    Pictograms

    Health hazardEnvironment
    GHS08,GHS09

    Signal Word

    Danger

    Hazard Statements

    H351,H360FD,H362,H410

    Hazard Classifications

    Aquatic Acute 1 - Aquatic Chronic 1 - Carc. 2 - Lact. - Repr. 1A

    WGK

    WGK 3

    Flash Point(F)

    Not applicable

    Flash Point(C)

    Not applicable

    Regulatory Information

    监管及禁止进口产品

    Choose from one of the most recent versions:

    Certificates of Analysis (COA)

    Lot/Batch Number

    Sorry, we don't have COAs for this product available online at this time.

    If you need assistance, please contact Customer Support.

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Xiaohui Xia et al.
    Annals of translational medicine, 8(12), 762-762 (2020-07-11)
    To explore the effect of estrogen on human cerebral vascular smooth muscle cells (VSMCs) and to clarify the molecular mechanism of estrogen inhibition of VSMC proliferation, which could provide an important reference basis for the clinical treatment of hypertensive intracerebral
    María Jesús López et al.
    Human reproduction (Oxford, England), 29(7), 1432-1437 (2014-05-02)
    How long is the individualized training and the stability of competence for the embryo transfer (ET) technique? The embryo transfer technique is easy-to-learn, hardly unlearned, and training should be individualized by monitoring with learning curve-cumulative summation (LC-CUSUM) curves. Like many
    Sadik Sahin et al.
    Archives of gynecology and obstetrics, 291(1), 185-191 (2014-08-01)
    The aim of this study was to compare the incidence of ectopic pregnancy in GnRH agonist triggered IVF cycles with intensive luteal support versus hCG triggered IVF cycles. This study was conducted as a retrospective cohort analysis of women who
    M Sousa et al.
    Zygote (Cambridge, England), 23(1), 145-157 (2013-09-03)
    Human oocyte dysmorphisms attain a large proportion of retrieved oocytes from assisted reproductive technology (ART) treatment cycles. Extracytoplasmic defects involve abnormal morphology of the zona pellucida (ZP), perivitelline space and first polar body. The aim of the present study was

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service